Logo image of TMCI

TREACE MEDICAL CONCEPTS INC (TMCI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TMCI - US89455T1097 - Common Stock

2.68 USD
-0.02 (-0.74%)
Last: 12/3/2025, 8:00:01 PM
2.68 USD
0 (0%)
After Hours: 12/3/2025, 8:00:01 PM
Fundamental Rating

3

TMCI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. TMCI may be in some trouble as it scores bad on both profitability and health. TMCI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TMCI had negative earnings in the past year.
TMCI had a negative operating cash flow in the past year.
In the past 5 years TMCI always reported negative net income.
In the past 5 years TMCI always reported negative operating cash flow.
TMCI Yearly Net Income VS EBIT VS OCF VS FCFTMCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of TMCI (-23.82%) is comparable to the rest of the industry.
TMCI has a Return On Equity (-50.38%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -23.82%
ROE -50.38%
ROIC N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
TMCI Yearly ROA, ROE, ROICTMCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

With an excellent Gross Margin value of 80.12%, TMCI belongs to the best of the industry, outperforming 92.55% of the companies in the same industry.
TMCI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for TMCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
TMCI Yearly Profit, Operating, Gross MarginsTMCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

TMCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TMCI has been increased compared to 1 year ago.
The number of shares outstanding for TMCI has been increased compared to 5 years ago.
Compared to 1 year ago, TMCI has a worse debt to assets ratio.
TMCI Yearly Shares OutstandingTMCI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
TMCI Yearly Total Debt VS Total AssetsTMCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

TMCI has an Altman-Z score of 0.32. This is a bad value and indicates that TMCI is not financially healthy and even has some risk of bankruptcy.
TMCI has a Altman-Z score of 0.32. This is comparable to the rest of the industry: TMCI outperforms 46.81% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that TMCI is somewhat dependend on debt financing.
TMCI has a Debt to Equity ratio of 0.56. This is in the lower half of the industry: TMCI underperforms 60.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC8.41%
TMCI Yearly LT Debt VS Equity VS FCFTMCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

TMCI has a Current Ratio of 3.52. This indicates that TMCI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.52, TMCI is in the better half of the industry, outperforming 64.36% of the companies in the same industry.
A Quick Ratio of 2.51 indicates that TMCI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.51, TMCI is in the better half of the industry, outperforming 61.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 2.51
TMCI Yearly Current Assets VS Current LiabilitesTMCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

TMCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
Looking at the last year, TMCI shows a quite strong growth in Revenue. The Revenue has grown by 11.89% in the last year.
TMCI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.66% yearly.
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4%
Revenue 1Y (TTM)11.89%
Revenue growth 3Y30.41%
Revenue growth 5Y39.66%
Sales Q2Q%11.37%

3.2 Future

Based on estimates for the next years, TMCI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
TMCI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.54% yearly.
EPS Next Y3.2%
EPS Next 2Y6.58%
EPS Next 3Y5.93%
EPS Next 5Y14.19%
Revenue Next Year9.29%
Revenue Next 2Y9.36%
Revenue Next 3Y8.8%
Revenue Next 5Y14.54%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TMCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TMCI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMCI Price Earnings VS Forward Price EarningsTMCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMCI Per share dataTMCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.58%
EPS Next 3Y5.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TMCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TREACE MEDICAL CONCEPTS INC

NASDAQ:TMCI (12/3/2025, 8:00:01 PM)

After market: 2.68 0 (0%)

2.68

-0.02 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners61.15%
Inst Owner Change47.72%
Ins Owners22.72%
Ins Owner Change-0.27%
Market Cap170.77M
Revenue(TTM)209.36M
Net Income(TTM)-49.18M
Analysts76.67
Price Target5.58 (108.21%)
Short Float %7.79%
Short Ratio5.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.74%
Min EPS beat(2)4.79%
Max EPS beat(2)18.69%
EPS beat(4)4
Avg EPS beat(4)26.96%
Min EPS beat(4)4.79%
Max EPS beat(4)74.58%
EPS beat(8)6
Avg EPS beat(8)12.12%
EPS beat(12)10
Avg EPS beat(12)15.41%
EPS beat(16)12
Avg EPS beat(16)-130.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)-1.02%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)1.65%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)9
Avg Revenue beat(12)1.82%
Revenue beat(16)13
Avg Revenue beat(16)2.27%
PT rev (1m)-37.13%
PT rev (3m)-35.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.8
P/FCF N/A
P/OCF N/A
P/B 1.75
P/tB 2.21
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.73
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS3.35
BVpS1.53
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.82%
ROE -50.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.12%
FCFM N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.07%
Cap/Sales 6.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.52
Quick Ratio 2.51
Altman-Z 0.32
F-Score3
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)349.5%
Cap/Depr(5y)305.94%
Cap/Sales(3y)7.38%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4%
EPS Next Y3.2%
EPS Next 2Y6.58%
EPS Next 3Y5.93%
EPS Next 5Y14.19%
Revenue 1Y (TTM)11.89%
Revenue growth 3Y30.41%
Revenue growth 5Y39.66%
Sales Q2Q%11.37%
Revenue Next Year9.29%
Revenue Next 2Y9.36%
Revenue Next 3Y8.8%
Revenue Next 5Y14.54%
EBIT growth 1Y26.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.63%
EBIT Next 3Y31.89%
EBIT Next 5Y26.75%
FCF growth 1Y44.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61.23%
OCF growth 3YN/A
OCF growth 5YN/A

TREACE MEDICAL CONCEPTS INC / TMCI FAQ

Can you provide the ChartMill fundamental rating for TREACE MEDICAL CONCEPTS INC?

ChartMill assigns a fundamental rating of 3 / 10 to TMCI.


Can you provide the valuation status for TREACE MEDICAL CONCEPTS INC?

ChartMill assigns a valuation rating of 0 / 10 to TREACE MEDICAL CONCEPTS INC (TMCI). This can be considered as Overvalued.


What is the profitability of TMCI stock?

TREACE MEDICAL CONCEPTS INC (TMCI) has a profitability rating of 2 / 10.


How financially healthy is TREACE MEDICAL CONCEPTS INC?

The financial health rating of TREACE MEDICAL CONCEPTS INC (TMCI) is 3 / 10.


Can you provide the expected EPS growth for TMCI stock?

The Earnings per Share (EPS) of TREACE MEDICAL CONCEPTS INC (TMCI) is expected to grow by 3.2% in the next year.